Pancreas Clinical Trial
Official title:
The Pancreas and the Bilio-pancreatic Junction: Is There a Pancreatic Segmentation Based on the Pancreatic Duct Branching?
Limited pancreatic resections are increasingly performed, but the rate of postoperative fistula is higher than after classical resections. Pancreatic segmentation, anatomically and radiologically identifiable, may theoretically help the surgeon removing selected anatomical portions with their own segmental pancreatic duct and thus might decrease the postoperative fistula rate. Current pancreatic segmentation theories do not enable defining anatomical-surgical pancreatic segments. To our knowledge, no study has tried to describe pancreatic segmentation from the divisions of the pancreatic ducts to date. Hence, we hypothesize to explore the possibility of pancreatic segmentation following pancreatic ducts, using extensive reconstructions of pancreatic duct using micro-scanner on injected human pancreas.
- In a first step, the injection technique will be developed (dilution, stability,
hardening of the contrast mixture).
- In a second step, we will inject the mixture in human pancreas: into the duct tree, the
vein and arteries. After hardening, the human pancreas will be removed from cadavers
following the organ donation technique. The anatomic specimens will be scanned in the
laboratory UMR CNRS 7369 MEDyC, Reims (Pr X. MAQUART, Dr J. DEVY).
- The images obtained (Dicom format) are very big in term of file size. Analysis of the
images will be performed using a supercomputer of the laboratory CReSTIC - ROMEO EA
3804, Reims (Dr A. RENARD, Pr M. KRAJEKI). 3D reconstructions will be performed.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT00557596 -
A Phase 1-2, XIAP Antisense AEG35156 With Gemcitabine in Patients With Advanced Pancreatic Cancer
|
Phase 1/Phase 2 | |
Completed |
NCT00707278 -
Radiation Therapy and Capecitabine/Oxaliplatin Chemotherapy in the Treatment of Locally Advanced Pancreas Adenocarcinoma
|
Phase 1 | |
Terminated |
NCT02244164 -
Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments.
|
N/A | |
Recruiting |
NCT02979483 -
Management of Symptomatic Advanced Pancreatic Adenocarcinoma
|
N/A | |
Completed |
NCT00497224 -
Phase II Trial of Erlotinib in Advanced Pancreatic Cancer
|
Phase 2 | |
Terminated |
NCT04764396 -
Assessing Effects of Heparin Priming and Pass Number on Tissue Quality of Fine Needle Biopsies
|
N/A | |
Completed |
NCT01169649 -
Study of MK-2206 in Patients With Metastatic Neuroendocrine Tumors (NET)
|
Phase 2 | |
Completed |
NCT04935216 -
Predictors of Postoperative Complications and Readmissions in Laparoscopic Pancreas Resection
|
||
Completed |
NCT00918853 -
Prospective Evaluation of the Resection Margins and the Ganglionic Status Using a Quality Standard Resection for Adenocarcinoma of the Head of the Pancreas
|
N/A | |
Completed |
NCT00936104 -
Side Population in Pancreatic Ductal Adenocarcinoma (PDAC)
|
N/A | |
Available |
NCT01786850 -
Magnetic Resonance-guided High-intensity Focused Ultrasound Treatment of Locally Advanced Pancreatic Cancer
|
N/A |